<DOC>
	<DOCNO>NCT01010139</DOCNO>
	<brief_summary>The objective study design characterize pharmacokinetics comparative bioavailability Roxane Laboratories ' codeine sulfate tablet oral administration 60 mg dos 1 x 60 mg , 2 x 30 mg 4 x 15 mg fast condition .</brief_summary>
	<brief_title>Pharmacokinetic Comparative Bioavailability Study Codeine Sulfate Under Fasted Conditions</brief_title>
	<detailed_description />
	<mesh_term>Codeine</mesh_term>
	<criteria>No clinically significant abnormal finding physical examination , medical history , clinical laboratory result screen . Positive test HIV , Hepatitis B , Hepatitis C. Treatment know enzyme alter drug . History allergic adverse response codeine sulfate comparable similar product .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2009</verification_date>
</DOC>